Mar 09, 2017 21:02 pm UTC| Business
RANCHO CUCAMONGA, Calif., March 09, 2017 -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2016 ended December 31, 2016, after the market closes...
Mar 09, 2017 21:02 pm UTC| Business
RANCHO CUCAMONGA, Calif., March 09, 2017 -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2016 ended December 31, 2016, after the market closes...
Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update
Mar 09, 2017 21:02 pm UTC| Business
Xtampza® ER prescribed by more than 2,400 physicians since commercial launchONSOLIS® patent issued that extends patent protection until 2027Well capitalized with $153.2 million in cash and cash equivalents CANTON, Mass.,...
Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update
Mar 09, 2017 21:02 pm UTC| Business
Xtampza® ER prescribed by more than 2,400 physicians since commercial launchONSOLIS® patent issued that extends patent protection until 2027Well capitalized with $153.2 million in cash and cash equivalents CANTON, Mass.,...
TearLab Corporation Reports Fourth Quarter and Year End 2016 Financial Results
Mar 09, 2017 21:02 pm UTC| Business
SAN DIEGO, March 09, 2017 -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended December 31, 2016....
TearLab Corporation Reports Fourth Quarter and Year End 2016 Financial Results
Mar 09, 2017 21:02 pm UTC| Business
SAN DIEGO, March 09, 2017 -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended December 31, 2016....
Cara Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 09, 2017 21:02 pm UTC| Business
STAMFORD, Conn., March 09, 2017 -- Cara Therapeutics, Inc. (NASDAQ:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...